Additionally, studies have shown that TWEAK-triggered Fn14 activation in cancer cells themselves can stimulate either “pro-tumorigenic/metastatic” or “anti-tumorigenic/metastatic” cellular responses in vitro, depending on the cell line under investigation. The gene discussed is TNFSF12; the disease is cancer.